Patterns of levetiracetam and lacosamide use for treatment of status epilepticus with respect to clinical features and prior antiseizure medications
Abstract Background The aim of this study was to evaluate the clinical usage of second-line intravenous antiseizure medications (IV ASMs), particularly levetiracetam (LEV) and lacosamide (LCM), in patients with status epilepticus (SE) in relation to their clinical characteristics and the use of pre-...
Gardado en:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BMC
2026-04-01
|
| Series: | BMC Neurology |
| Assuntos: | |
| Acceso en liña: | https://doi.org/10.1186/s12883-026-04854-0 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|